Alfonso Iorio

Alfonso Iorio

McMaster University

H-index: 70

North America-Canada

About Alfonso Iorio

Alfonso Iorio, With an exceptional h-index of 70 and a recent h-index of 54 (since 2020), a distinguished researcher at McMaster University, specializes in the field of Knowledge translation, Hemophilia, Clinical Prediction.

His recent articles reflect a diverse array of research interests and contributions to the field:

GRADE Concept Paper 8: Judging the certainty of discrimination performance estimates of prognostic models in a body of validation studies

Lower-dose emicizumab prophylaxis: can less be more?

Health utilities in adults with hemophilia A: A retrospective cohort study

Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study

Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in …

Grading of recommendations, assessment, development and evaluations concept 7: issues and insights linking guideline recommendations to trustworthy essential medicine lists

GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists

Attitudes and Perceptions of Medical Researchers Towards the Use of Artificial Intelligence Chatbots in the Scientific Process: A Large-Scale, International Cross-Sectional Survey

Alfonso Iorio Information

University

Position

Professor and Chair Department of Health Research Methods Evidence and Impact

Citations(all)

29330

Citations(since 2020)

14266

Cited By

19157

hIndex(all)

70

hIndex(since 2020)

54

i10Index(all)

276

i10Index(since 2020)

196

Email

University Profile Page

Google Scholar

Alfonso Iorio Skills & Research Interests

Knowledge translation

Hemophilia

Clinical Prediction

Top articles of Alfonso Iorio

GRADE Concept Paper 8: Judging the certainty of discrimination performance estimates of prognostic models in a body of validation studies

2024/4/3

Lower-dose emicizumab prophylaxis: can less be more?

Journal of Thrombosis and Haemostasis

2024/4/1

Alfonso Iorio
Alfonso Iorio

H-Index: 47

Health utilities in adults with hemophilia A: A retrospective cohort study

Haemophilia

2024/3/20

Alfonso Iorio
Alfonso Iorio

H-Index: 47

Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study

Haemophilia

2024/3/4

Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in …

Haemophilia

2024/2/20

Grading of recommendations, assessment, development and evaluations concept 7: issues and insights linking guideline recommendations to trustworthy essential medicine lists

Journal of Clinical Epidemiology

2023/8/1

GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists

Journal of Clinical Epidemiology

2024/2

Thomas Piggott
Thomas Piggott

H-Index: 6

Alfonso Iorio
Alfonso Iorio

H-Index: 47

Attitudes and Perceptions of Medical Researchers Towards the Use of Artificial Intelligence Chatbots in the Scientific Process: A Large-Scale, International Cross-Sectional Survey

medRxiv

2024

Machine learning to increase the efficiency of a literature surveillance system: a performance evaluation

medRxiv

2023

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review

2023/1/1

Flora Peyvandi
Flora Peyvandi

H-Index: 49

Alfonso Iorio
Alfonso Iorio

H-Index: 47

Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature

2023/1

Alfonso Iorio
Alfonso Iorio

H-Index: 47

Erik Berntorp
Erik Berntorp

H-Index: 39

The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients

Research and Practice in Thrombosis and Haemostasis

2023/11/1

OC 06.5 Use of Emicizumab for the Treatment of Acquired Hemophilia A: A Systematic Review

2023/10/1

OC 24.1 Effect of the Type of F9 Mutation on the Pharmacokinetic Profile of Patients with Hemophilia B Treated with Extended Half-Life FIX Concentrates

Research and Practice in Thrombosis and Haemostasis

2023/10/1

OC 24.2 Estimated Factor VIII Activity Levels at the Time of Bleeding Events in Individuals with Hemophilia a Without Inhibitors

2023/10/1

OC 24.4 Effect of F8 Mutations and Von Willebrand Factor on Pharmacokinetics of FVIII Concentrates in Severe Hemophilia A

Research and Practice in Thrombosis and Haemostasis

2023/10/1

Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study

Research and Practice in Thrombosis and Haemostasis

2023/10/1

PB2647: USE OF EMICIZUMAB FOR THE TREATMENT OF ACQUIRED HEMOPHILIA A: A SYSTEMATIC REVIEW

2023/8/1

Alfonso Iorio
Alfonso Iorio

H-Index: 47

Davide Matino
Davide Matino

H-Index: 16

PB2629: LATE DIAGNOSIS OF TWO ADULT SIBLINGS WITH BERNARD SOULIER SYNDROME (BSS)

HemaSphere

2023/8/1

Davide Matino
Davide Matino

H-Index: 16

Alfonso Iorio
Alfonso Iorio

H-Index: 47

See List of Professors in Alfonso Iorio University(McMaster University)

Co-Authors

academic-engine